(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

What is it about?

In a Randomized Clinical Trial of individuals with Alcohol Use Disorder, gabapentin (relative to placebo) interacted with abstinence during early treatment to increase glutamate (primary excitatory neurotransmitter), and decrease GABA (primary inhibitory neurotransmitter), levels in abstinent individuals. Gabapentin-treated participants with increased glutamate levels demonstrated significantly more percent days abstinent over the remainder of treatment. These effects on a key neurochemical system could be a model for future AUD pharmacotherapy development/efficacy.

Read more on Kudos…
The following have contributed to this page:
James Prisciandaro
' ,"url"));